{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:42:19Z","timestamp":1771573339691,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","award":["ID 573839\/2008-5"],"award-info":[{"award-number":["ID 573839\/2008-5"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006125","name":"National Institute for Interdisciplinary Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006675","name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Doen\u00e7as Tropicais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cellimm.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T01:56:00Z","timestamp":1538790960000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM\/TSP"],"prefix":"10.1016","volume":"334","author":[{"given":"Mariele","family":"Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselmo","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia B.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davi","family":"Tanajura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana S.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvane","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2018.09.009_b0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200312150-00013","article-title":"HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics","volume":"34","author":"Dourado","year":"2003","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.cellimm.2018.09.009_b0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1590\/S0102-311X2005000300027","article-title":"Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I\/II): serological screening prevalence rates in blood donors from large urban areas in Brazil","volume":"21","author":"Catalan-Soares","year":"2005","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.cellimm.2018.09.009_b0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2018.09.009_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/S1677-55382007000200016","article-title":"Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals","volume":"33","author":"Castro","year":"2007","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2006.0140","article-title":"Clinical manifestations associated with HTLV type I infection: a cross-sectional study","volume":"23","author":"Caskey","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2018.09.009_b0040","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.urology.2009.11.041","article-title":"Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder","volume":"75","author":"Oliveira","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.cellimm.2018.09.009_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/civ229","article-title":"Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study","volume":"61","author":"Tanajura","year":"2015","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.cellimm.2018.09.009_b0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I-associated myelopathy (TSP\/HAM)","volume":"22","author":"De Castro-Costa","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.cellimm.2018.09.009_b0055","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","article-title":"High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease","volume":"77","author":"Goon","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos","year":"2004","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cellimm.2018.09.009_b0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0070","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jmv.22087","article-title":"Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients according to new diagnostic criteria of HAM\/TSP","volume":"83","author":"Grassi","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000205","article-title":"Alteration of blood-brain barrier integrity by retroviral infection","volume":"4","author":"Afonso","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellimm.2018.09.009_b0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.179.227","article-title":"Increased production of inflammatory cytokines in cultured CD4+ cells from patients with HTLV-I-associated myelopathy","volume":"179","author":"Nishiura","year":"1996","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.cellimm.2018.09.009_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"97","author":"Nishimoto","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cellimm.2018.09.009_b0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S0004-282X1997000100024","article-title":"Cerebrospinal fluid analysis and the pathogenesis of central nervous system infection by HTLV-I","volume":"55","author":"Puccioni-Sohler","year":"1997","journal-title":"Arq. Neuropsiquiatria"},{"key":"10.1016\/j.cellimm.2018.09.009_b0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.0022-202X.2005.23841.x","article-title":"Chemokines: key players in innate and adaptive immunity","volume":"125","author":"Esche","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"Suppl. 4","key":"10.1016\/j.cellimm.2018.09.009_b0100","first-page":"967","article-title":"The chemokines and their receptors: characteristics and physiological functions","volume":"24","author":"Guerreiro","year":"2011","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.cellimm.2018.09.009_b0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2004.10.011","article-title":"CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha","volume":"159","author":"Narikawa","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","article-title":"Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)\/tropical spastic paraparesis (HAM\/TSP) disease from HTLV-1 carrier state","volume":"145","author":"Guerreiro","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0115","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","article-title":"Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis","volume":"71","author":"Tanaka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2018.09.009_b0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2017.00531","article-title":"Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients","volume":"8","author":"Khaibullin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1067\/mai.2000.110813","article-title":"Road signs guiding leukocytes along the inflammation superhighway","volume":"106","author":"Bochner","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0130","first-page":"219","article-title":"The role of T-cell-mediated mechanisms in virus infections of the nervous system","volume":"253","author":"Dorries","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0135","unstructured":"H. Seller. Cellular Adhesion and Adhesion Molecules25 (2001) 1\u201315."},{"key":"10.1016\/j.cellimm.2018.09.009_b0140","first-page":"91","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1): an overview","volume":"15","author":"Witkowska","year":"2004","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cellimm.2018.09.009_b0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410410307","article-title":"Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis","volume":"41","author":"Rieckmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000049007","article-title":"Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement","volume":"9","author":"Baraczka","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.cellimm.2018.09.009_b0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004010050435","article-title":"Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"91","author":"Umehara","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-5728(98)00084-8","article-title":"Intercellular adhesion molecule-1 in cerebrospinal fluid\u2013the evaluation of blood-derived and brain-derived fractions in neurological diseases","volume":"87","author":"Lewczuk","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0165","first-page":"757","article-title":"Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease","volume":"21","author":"Golias","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.cellimm.2018.09.009_b0170","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/jmv.23341","article-title":"Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection","volume":"84","author":"Santos","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(00)00229-5","article-title":"A practical approach to multicolor flow cytometry for immunophenotyping","volume":"243","author":"Baumgarth","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2018.09.009_b0180","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/368379","article-title":"Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis and asymptomatic HTLV-I carriers","volume":"187","author":"Furukawa","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2018.09.009_b0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12985-015-0398-x","article-title":"HAM\/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous System","volume":"12","author":"Gudo","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.cellimm.2018.09.009_b0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","article-title":"Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity","volume":"20","author":"Starling","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/j.cellimm.2018.09.009_b0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1","volume":"13","author":"Santos","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.cellimm.2018.09.009_b0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.cellimm.2018.09.009_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002479","article-title":"CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"7","author":"Sato","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cellimm.2018.09.009_b0210","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jmv.24481","article-title":"Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers","volume":"88","author":"Chaves","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0215","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/brain\/awt183","article-title":"Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy","volume":"136","author":"Ando","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cellimm.2018.09.009_b0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(95)00023-U","article-title":"Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy","volume":"59","author":"Matsuda","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0225","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneurol.2011.148","article-title":"Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica","volume":"68","author":"Uzawa","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cellimm.2018.09.009_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.1999.1580","article-title":"Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased","volume":"198","author":"Al-Fahim","year":"1999","journal-title":"Cell Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918304416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918304416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:20:27Z","timestamp":1762107627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874918304416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"alternative-id":["S0008874918304416"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.09.009","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM\/TSP","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}